Abstract
Ranolazine, an antianginal and antiarrhythmic drug blocking slow inactivating persistent sodium currents, is described as a compound with anticonvulsant potential. Since arrhythmia often accompanies seizures, patients suffering from epilepsy are frequently co-treated with antiepileptic and antiarrhythmic drugs. The aim of this study was to evaluate the effect of ranolazine on maximal-electroshock (MES)-induced seizures in mice as well as interactions between ranolazine and classical antiepileptic drugs in this model of epilepsy. Types of pharmacodynamic interactions were established by isobolographic analysis of obtained data. The main findings of the study were that ranolazine behaves like an antiseizure drug in the MES test. Moreover, ranolazine interacted antagonistically with carbamazepine, phenytoin, and phenobarbital in the proportions of 1:3 and 1:1. These interactions occurred pharmacodynamic, since ranolazine did not change the brain levels of antiepileptic drugs measured in the fluorescence polarization immunoassay. Ranolazine and its combinations with carbamazepine, phenytoin, and phenobarbital did not impair motor coordination evaluated in the chimney test. Unfortunately, an attempt to conduct a passive avoidance task (evaluating long-term memory) resulted in ranolazine-induced delayed lethality. In conclusion, ranolazine exhibits clear-cut anticonvulsant properties in the MES test but interacts antagonistically with some antiepileptic drugs. The obtained results need confirmation in clinical studies. The mechanisms of ranolazine-induced toxicity require specific explanation.
Funder
Medical University of Lublin
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference36 articles.
1. Ranolazine as a promising treatment option for atrial fibrillation: Electrophysiologic mechanisms, experimental evidence, and clinical implications;Fragakis;Pacing Clin. Electrophysiol.,2014
2. Borowicz-Reutt, K.K. (2022). Effects of antiarrhythmic drugs on antiepileptic drug action—A critical review of experimental findings. Int. J. Mol. Sci., 23.
3. Through the heart and beyond: A review on ranolazine;Uran;Monaldi Arch. Chest Dis.,2021
4. Open-label pilot study of ranolazine for cramps in amyotrophic lateral sclerosis;Chandrashekhar;Muscle Nerv.,2022
5. Rouhana, S., Virsolvy, A., Fares, N., Richard, S., and Thireau, J. (2022). Ranolazine: An old drug with emerging potential; lessons from pre-clinical and clinical investigations for possible repositioning. Pharmaceuticals, 15.